Delivery Order SPE2DR25D1201-SPE2DR26FALFM
Award Date 3/11/26
Potential Completion Date 3/12/26
Potential Value $18K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $11,347.49 delivery order to AmerisourceBergen Drug Corp on March 9, 2026, for Jardiance 25 mg tablets (90-count supply) under firm fixed pricing, with ultimate completion by March 10, 2026. Place of performance is Conshohocken, PA. The order was issued on a non-competitive basis without set-aside designation. AmerisourceBergen Drug Corp operates under its parent company Cencora, Inc., and executes deliveries through the DLA Troop Support Medical...
- The Defense Logistics Agency issued a $4,109.90 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Jardiance 25 mg tablets (90-count). The order is issued under the parent IDC held by Cencora, Inc. (Amerisourcebergen's parent), a $999,999,999 indefinite delivery contract with DLA Troop Support Medical through December 2026 that supplies pharmaceutical products and medical supplies globally to military healthcare programs. Place of performance is Conshohocken, PA. Ultimate...
- The Defense Logistics Agency issued a $4,812.39 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Jardiance 25 mg tablets (90-count). The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. Place of performance is Conshohocken, PA. The order carries a firm fixed price and ultimate completion date of March 3, 2026.
- The Defense Logistics Agency issued a $5,462.06 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for Jardiance 10 mg tablets (90-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) with Cencora, Inc., Amerisourcebergen's parent company, valued at up to $999,999,999 through December 2031. This IDC provides pharmaceutical and medical supply procurement globally to support military healthcare programs. Place of performance is...
- The Defense Logistics Agency issued a $6,579.63 delivery order to AmerisourceBergen Drug Corp on March 10, 2026, for Jardiance 25 mg tablets (90-count supply). The order is firm fixed price with an ultimate completion date of March 11, 2026. Place of performance is Conshohocken, PA. The delivery order was issued under the DLA Troop Support Medical Indefinite Delivery Contract, a single-award IDC valued at up to $999,999,999 through December 2026, which supplies pharmaceutical products and...
- The Defense Logistics Agency issued a $27,469.08 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for Jardiance 25 mg tablets (90-count units) under firm fixed pricing, with ultimate completion by March 11, 2026. Place of performance is Conshohocken, PA. The order was not set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement, particularly the Defense Health Agency and military healthcare...
- The Defense Logistics Agency issued a $5,678.26 delivery order to AmerisourceBergen Drug Corp on March 3, 2026, for Jardiance 25 mg tablets (90-count supply), with an ultimate completion date of March 4, 2026. The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and...
- The Defense Logistics Agency issued a $45,270.27 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Jardiance 25 mg tablets (90-count supply). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed pricing with an ultimate completion date of March 6,...
- The Defense Logistics Agency issued a $55,427.36 delivery order to AmerisourceBergen Drug Corp on March 6, 2026, for Jardiance 25 mg tablets (90-count supply) with a firm fixed price and ultimate completion date of March 9, 2026. Place of performance is Conshohocken, PA. The order was issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling...
- The Defense Logistics Agency issued a $5,191.57 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for supply of Jardiance 10 mg tablets (90-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed-price structure and...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FALFMDelivery Order
The Defense Logistics Agency issued a $17,694.91 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for Jardiance 25 mg tablets (90-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999.00 through December 2026, which provides global pharmaceutical support to military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. Place of performance is Conshohocken, PA. The order carries a firm fixed price and has an ultimate completion date of March 12, 2026. No set-aside applies.
Generated 6/9/26, 10:22 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 3/10/26 |